SHS buys healthcare service Medigroba

The all-equity deal was sourced proprietarily by SHS. The investor bought the company alongside two private investors from the medtech industry, who will take over the management. Previous managing partner Stefan Allgayer will leave Medigroba after a transition period. Together with the other heirs to the family business, he made the decision to sell after leading the business for five years. 

Apart from organic growth, SHS plans add-on acquisitions for the homecare provider. The company, which currently operates only in the state of Baden-Wurttemberg, hopes to expand operations across Germany. SHS said the homecare sector is currently expanding, as cost pressure induces hospitals to release patients earlier, thereby shifting the healing process to the domestic environment.

The acquisition was made via SHS's fourth fund. Including reserved funds for further investments in the currently 11 portfolio companies, the vehicle is 70% invested. SHS plans to hit the fundraising trail again within the next two years.  

Company
Founded in 1975, Medigroba is a homecare company situated in Balingen. It supplies patients in hospitals, nursing facilities and at home with medical aid and care products. It focuses on services as well as supplying medical technology products for wound and stoma treatment, liquid, probe and intravenous nutrition, pain therapy and children's intensive care. Medigroba currently employs 70 people.

People
SHS Gesellschaft für Beteiligungsmanagement – Uwe Steinbacher (managing partner).
Medigroba – Frank Franzen (managing director).

Advisers
Equity - Roos Legal, Markus Herz (legal); Mauer, Florian Kalbfelder (corporate finance).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Buyouts
• DACH
• Healthcare
• Germany